Health is one of the largest areas of UK innovation funding, and one of the hardest to read from the outside. The money comes from Innovate UK, the Office for Life Sciences, the NHS, the National Institute for Health and Care Research and a scattering of smaller programmes, and each one wants something slightly different.
The useful way to sort it is not by funder but by how far along your product is. A company with an idea and no data needs a completely different grant from a company with a working device that now has to prove itself in hospitals. Apply to the wrong stage and the assessors will notice in the first paragraph.
The three stages health funders pay for
An idea, tested quickly. Small, fast awards, often a few thousand pounds to tens of thousands, for a feasibility study or a proof of concept. Many are set as challenges, where an organisation describes a problem it has and asks companies to propose a fix. You don't need a finished product, and you often don't need a partner.
A product, developed and validated. Larger collaborative projects, usually through Innovate UK, that take a technology from the lab towards something a clinician could use. These are where the hundreds of thousands and the low millions sit. Expect to need a partner, match funding and a clear route to market.
A product, proven in the NHS. Money to show that something works in real care settings, across more than one site, with the evidence a buyer or regulator needs. This is the stage most health technology companies underestimate. A device that works is not the same as a device the NHS will buy.
Most of the grants below sit clearly in one of these three. Read them with your own stage in mind.
Six open right now
All six were open when we wrote this, with the closing dates shown. Deadlines move and rounds close, so check a competition is still open before you start on it.
N-CODE Innovation Challenge: the future of neurological healthcare — up to £12,000, closes 18 November 2026. The most accessible entry point here. N-CODE wants early-stage ideas that move neurological care, for conditions such as epilepsy, dementia and stroke, out of hospitals and closer to home, using wearables, digital biomarkers, AI or mathematical modelling. Industry-led proposals can win up to £12,000 each, with three to five winners, for projects of no more than eight weeks. UK-registered businesses can apply, and you don't need a finished solution.
iX Challenge: microfluidic diagnostic cartridges — £60,000, closes 6 November 2026. A very specific problem from a company called Beyond Blood Diagnostics: its handheld blood analyser loses some cells inside its disposable plastic cartridge, and the measurements vary more than clinicians will accept. It wants a way to prevent, tolerate or correct for that, inside a cartridge that can be mass-produced. If your business works in surface chemistry, microfluidics or image correction, this is a paid problem with a named buyer.
Engineering Biology Collaborative R&D: Round 3 — projects of £750,000 to £2.5 million, closes 3 November 2026. Innovate UK funding for business-led research where the core innovation comes from engineered biological systems: biosensors and diagnostics, biomanufacturing, engineered proteins, gene editing and more. Up to 70% of costs can be covered, depending on business size. Two details matter. The project must include at least one named end user further down the supply chain, and it cannot start before 1 April 2027.
Advancing innovation in accelerated cancer diagnosis — projects of £1.5 million to £4 million, closes 28 October 2026. Part of a £25.4 million Office for Life Sciences programme, run by Innovate UK, to validate and evaluate early cancer diagnostic technologies in the clinic. Projects on less common cancers, meaning anything other than breast, prostate, lung and bowel, are particularly encouraged. Innovate UK puts the chance of success at around 15%, which tells you how carefully the application needs to be built.
NHS Cancer Programme: Innovation Open Call 4 — up to £3 million, closes 1 December 2026. The third stage at its clearest. Projects must put a solution into use and measure its impact across several NHS sites in England, aimed either at freeing capacity on cancer pathways or at earlier detection and diagnosis. Under the first strand, projects of up to £3 million over 24 months can claim 100% of costs, with no match funding. A second strand offers up to £5 million for the first two years of a three-year project, with the third year paid by the local NHS.
Visa Fees Reimbursement Scheme for Scale Ups — £500 to £25,000 a year, closes 2 March 2027. Not an R&D grant, and easy to miss for that reason. The Department for Business and Trade pays back visa fees for international hires at UK scale-ups in life sciences, clean energy, and digital and technologies, up to £5,000 per hire and their dependants and £25,000 a year in total. Costs from before you apply don't count, so apply before the hire, not after.
Also worth knowing about
NIHR Invention for Innovation (i4i). The NIHR's product development programme for medical technology, closing 2 December 2026 for its current round. Its Product Development Awards start with a short outline application, and a joint call with Singapore's National Health Innovation Centre offers up to £500,000 in the UK for late-stage development and evaluation over up to 24 months.
Engineering Biology Investor Partnerships. Grants of £250,000 to £2 million for close-to-market engineering biology projects, also closing 2 December 2026, with a catch that is also its point: you must secure matching investment from a lead investor in the programme's pool. Innovate UK suggests about a 20% chance of success.
The large capital funds. For companies building factories rather than products, the Life Sciences Innovative Manufacturing Fund covers projects of £8 million or more, and a new £50 million Transformational R&D Investment Fund pilot is for projects costing at least £100 million, typically with 10% to 20% of costs as grant. We covered the manufacturing fund in more detail in our guide to manufacturing grants for UK businesses.
Before you apply
Name your stage honestly. An idea, a product in development or a product ready for the NHS. Each grant above is built for one of these, and stretching a feasibility idea into a clinical validation bid rarely survives assessment.
Find your NHS partner early. Almost every larger health grant expects clinical involvement, and the NHS Cancer Programme call needs several sites. Those conversations take months, not weeks.
Check the cost rules. Some of these pay all project costs and some pay up to 70%, and the difference can decide whether you can afford to apply at all. Our guide to innovation grants for UK businesses explains grant rates, match funding and eligible costs in plain terms.
Look beyond the obvious funder. The challenge-style calls, like N-CODE and the iX microfluidics problem, are run through Innovate UK Business Connect rather than the main competition portal, and they're among the easiest for a small company to win.
Finding health innovation grants on Grants Hub
Health innovation funding is published by Innovate UK, government departments, the NIHR, the NHS and challenge programmes, and new rounds open every few weeks. Grants Hub lists them alongside 4,900+ live UK funding opportunities from 2,300+ funders, checked daily. Search by what your product does rather than by funder name, and set an alert so the next round reaches you with time to find your clinical partner. We take 0% commission on anything you win.